PHARMACORD NAMES PATRICK LEE CHIEF FINANCIAL OFFICER
LOUISVILLE, KY – November 15, 2018 – PharmaCord, LLC, a rapidly growing patient services company that provides customized solutions to the biopharmaceutical industry, announced today that Patrick Lee has been named Chief Financial Officer. Lee has served since April 2018 as Vice President of Strategy for PharmaCord where he has held responsibility for corporate development and other growth-oriented company initiatives.
“Since joining PharmaCord earlier this year, Patrick has played a critical role in driving a number of key initiatives that helped fuel our growth,” commented Nitin Sahney, PharmaCord’s founder and Chief Executive Officer. “His unique blend of financial acumen and operational discipline make him ideally suited to serve as our CFO. I look forward to the many contributions he will bring to the organization in his expanded role.”
Throughout his career, Lee has held a variety of finance, strategy and product development positions across several different sectors. He has extensive experience within the pharmaceutical supply chain, having served in executive roles at companies ranging from new innovative healthcare entrants to Fortune 10 companies that span the spectrum in patient services. Prior to PharmaCord, Lee led the product and business development efforts for CVS Health’s institutional pharmacy business. Before CVS Health, Lee served as Senior Vice President, Strategy and Investor Relations for Omnicare, Inc., a leading provider of complex pharmaceutical care. Prior to joining Omnicare in 2008, Lee held financial, operational and investor relations leadership roles for Gevity HR, Inc. (now TriNet Group, Inc.) and Zale Corporation (now Signet Jewelers Ltd.).
Lee holds a bachelor’s degree of business administration (BBA) in international business and economics from Loyola University Maryland and a master’s degree in professional accounting (MPA) from the University of Texas at Arlington.
PharmaCord is the connector between manufacturers, patients, physicians, and payors. The company provides customized patient solutions which span four core service categories; access services, patient support, pharmacy services and manufacturer services. These integrated services are designed to increase accessibility, clinical oversight and market acceptance of prescription therapy. Independently owned and organically built, PharmaCord is free from any competing priorities, enabling it to design and implement patient access and support programs that align with the objectives of its biopharmaceutical clients. PharmaCord’s experienced team coupled with its proprietary CORscendÔ technology platform optimizes workflow to deliver improved program execution, more rapid therapy initiation and increased patient engagement. To learn more about how PharmaCord improves commercial outcomes for manufacturers by providing the right connections, visit pharmacord.com.
# # #